ARCAPTA NEOHALER vs SPIRIVA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 6, 2026·How we rate

Possible drug interaction. ARCAPTA NEOHALER and SPIRIVA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	ARCAPTA NEOHALER	SPIRIVA
Rating	70/100	68/100
Pharmacy pays	—	~$353.74 /30
Type	RX	RX
Active ingredient	INDACATEROL MALEATE	TIOTROPIUM BROMIDE
Manufacturer	Novartis	Boehringer Ingelheim
Dosage forms	Powder	Capsule
Drug class	—	Anticholinergic
Boxed warning	None	None
Treats	Pulmonary Emphysema, Chronic Bronchitis	Pulmonary Emphysema, Chronic Bronchitis

arcapta neohaler spiriva

Rating

70/100

68/100

Pharmacy pays

—

~$353.74 /30

Type

Active ingredient

INDACATEROL MALEATE

TIOTROPIUM BROMIDE

Manufacturer

Novartis

Boehringer Ingelheim

Dosage forms

Powder

Capsule

Drug class

—

Anticholinergic

Boxed warning

None

Treats

Pulmonary Emphysema, Chronic Bronchitis

Frequently asked questions

Which is better-rated, Arcapta Neohaler or Spiriva?

By our independent rating, Arcapta Neohaler scores higher — 3.5 vs 3.4 out of 5 for Spiriva. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Arcapta Neohaler and Spiriva?

Arcapta Neohaler contains Indacaterol Maleate, while Spiriva contains Tiotropium Bromide — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.